nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—CYP2C9—brain cancer	0.469	1	CbGaD
Amiodarone—CYP2D6—Lomustine—brain cancer	0.0469	0.178	CbGbCtD
Amiodarone—CYP1A2—Carmustine—brain cancer	0.0464	0.176	CbGbCtD
Amiodarone—CYP2D6—Hydroxyurea—brain cancer	0.0355	0.135	CbGbCtD
Amiodarone—CYP3A4—Temozolomide—brain cancer	0.0351	0.133	CbGbCtD
Amiodarone—CYP3A4—Lomustine—brain cancer	0.0298	0.113	CbGbCtD
Amiodarone—CYP3A5—Etoposide—brain cancer	0.0185	0.0703	CbGbCtD
Amiodarone—CYP2C8—Etoposide—brain cancer	0.0178	0.0676	CbGbCtD
Amiodarone—CYP1A2—Etoposide—brain cancer	0.0137	0.0523	CbGbCtD
Amiodarone—ABCB1—Etoposide—brain cancer	0.012	0.0457	CbGbCtD
Amiodarone—CYP3A4—Etoposide—brain cancer	0.0072	0.0274	CbGbCtD
Amiodarone—THRB—hindbrain—brain cancer	0.00232	0.0507	CbGeAlD
Amiodarone—THRA—hindbrain—brain cancer	0.00232	0.0507	CbGeAlD
Amiodarone—THRB—brainstem—brain cancer	0.00133	0.0291	CbGeAlD
Amiodarone—THRA—brainstem—brain cancer	0.00133	0.0291	CbGeAlD
Amiodarone—EBP—endocrine gland—brain cancer	0.00127	0.0276	CbGeAlD
Amiodarone—THRA—telencephalon—brain cancer	0.00118	0.0258	CbGeAlD
Amiodarone—CACNA2D2—telencephalon—brain cancer	0.00117	0.0255	CbGeAlD
Amiodarone—THRA—gonad—brain cancer	0.000987	0.0215	CbGeAlD
Amiodarone—THRB—gonad—brain cancer	0.000987	0.0215	CbGeAlD
Amiodarone—THRB—pituitary gland—brain cancer	0.000963	0.021	CbGeAlD
Amiodarone—CACNA2D2—pituitary gland—brain cancer	0.000953	0.0208	CbGeAlD
Amiodarone—CACNA2D2—midbrain—brain cancer	0.00084	0.0183	CbGeAlD
Amiodarone—THRA—spinal cord—brain cancer	0.000828	0.0181	CbGeAlD
Amiodarone—CACNA2D2—spinal cord—brain cancer	0.00082	0.0179	CbGeAlD
Amiodarone—CACNA1H—gonad—brain cancer	0.000792	0.0173	CbGeAlD
Amiodarone—CACNA1H—pituitary gland—brain cancer	0.000773	0.0169	CbGeAlD
Amiodarone—THRB—endocrine gland—brain cancer	0.000746	0.0163	CbGeAlD
Amiodarone—THRA—endocrine gland—brain cancer	0.000746	0.0163	CbGeAlD
Amiodarone—CACNA2D2—endocrine gland—brain cancer	0.000738	0.0161	CbGeAlD
Amiodarone—THRA—head—brain cancer	0.000736	0.0161	CbGeAlD
Amiodarone—THRB—head—brain cancer	0.000736	0.0161	CbGeAlD
Amiodarone—CACNA2D2—head—brain cancer	0.000728	0.0159	CbGeAlD
Amiodarone—THRB—central nervous system—brain cancer	0.000672	0.0147	CbGeAlD
Amiodarone—THRA—central nervous system—brain cancer	0.000672	0.0147	CbGeAlD
Amiodarone—CACNA2D2—central nervous system—brain cancer	0.000665	0.0145	CbGeAlD
Amiodarone—THRB—cerebellum—brain cancer	0.000657	0.0143	CbGeAlD
Amiodarone—THRA—cerebellum—brain cancer	0.000657	0.0143	CbGeAlD
Amiodarone—CACNA2D2—cerebellum—brain cancer	0.00065	0.0142	CbGeAlD
Amiodarone—CYP3A7—endocrine gland—brain cancer	0.000637	0.0139	CbGeAlD
Amiodarone—CACNA1H—endocrine gland—brain cancer	0.000598	0.0131	CbGeAlD
Amiodarone—ADRB1—telencephalon—brain cancer	0.000564	0.0123	CbGeAlD
Amiodarone—SIGMAR1—telencephalon—brain cancer	0.000541	0.0118	CbGeAlD
Amiodarone—THRB—brain—brain cancer	0.000534	0.0116	CbGeAlD
Amiodarone—THRA—brain—brain cancer	0.000534	0.0116	CbGeAlD
Amiodarone—CACNA2D2—brain—brain cancer	0.000528	0.0115	CbGeAlD
Amiodarone—CACNA1H—cerebellum—brain cancer	0.000527	0.0115	CbGeAlD
Amiodarone—CYP2D6—hindbrain—brain cancer	0.000516	0.0113	CbGeAlD
Amiodarone—SIGMAR1—pituitary gland—brain cancer	0.000441	0.00962	CbGeAlD
Amiodarone—KCNH2—telencephalon—brain cancer	0.000431	0.00941	CbGeAlD
Amiodarone—CACNA1H—brain—brain cancer	0.000428	0.00935	CbGeAlD
Amiodarone—SIGMAR1—medulla oblongata—brain cancer	0.000425	0.00928	CbGeAlD
Amiodarone—Hepatic failure—Temozolomide—brain cancer	0.000425	0.00257	CcSEcCtD
Amiodarone—Pancreatitis—Hydroxyurea—brain cancer	0.000414	0.0025	CcSEcCtD
Amiodarone—Hot flush—Temozolomide—brain cancer	0.000408	0.00246	CcSEcCtD
Amiodarone—Flushing—Procarbazine—brain cancer	0.000406	0.00245	CcSEcCtD
Amiodarone—Dermatitis exfoliative—Temozolomide—brain cancer	0.000405	0.00244	CcSEcCtD
Amiodarone—Menopausal symptoms—Temozolomide—brain cancer	0.000405	0.00244	CcSEcCtD
Amiodarone—Skin exfoliation—Etoposide—brain cancer	0.000402	0.00243	CcSEcCtD
Amiodarone—Pancytopenia—Hydroxyurea—brain cancer	0.000401	0.00242	CcSEcCtD
Amiodarone—Neuropathy—Etoposide—brain cancer	0.000395	0.00239	CcSEcCtD
Amiodarone—Neutropenia—Hydroxyurea—brain cancer	0.000395	0.00239	CcSEcCtD
Amiodarone—Arrhythmia—Procarbazine—brain cancer	0.00039	0.00236	CcSEcCtD
Amiodarone—CYP2A6—cerebellum—brain cancer	0.00039	0.00852	CbGeAlD
Amiodarone—ABCB1—blood vessel—brain cancer	0.00039	0.0085	CbGeAlD
Amiodarone—SIGMAR1—midbrain—brain cancer	0.000389	0.00849	CbGeAlD
Amiodarone—Body temperature increased—Lomustine—brain cancer	0.000387	0.00233	CcSEcCtD
Amiodarone—Alopecia—Procarbazine—brain cancer	0.000386	0.00233	CcSEcCtD
Amiodarone—Weight increased—Hydroxyurea—brain cancer	0.000385	0.00232	CcSEcCtD
Amiodarone—SIGMAR1—spinal cord—brain cancer	0.000379	0.00828	CbGeAlD
Amiodarone—Ataxia—Carmustine—brain cancer	0.000372	0.00224	CcSEcCtD
Amiodarone—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000369	0.00223	CcSEcCtD
Amiodarone—Liver function test abnormal—Carmustine—brain cancer	0.000365	0.0022	CcSEcCtD
Amiodarone—Ataxia—Temozolomide—brain cancer	0.000359	0.00217	CcSEcCtD
Amiodarone—Tremor—Procarbazine—brain cancer	0.000356	0.00215	CcSEcCtD
Amiodarone—ADRB1—endocrine gland—brain cancer	0.000356	0.00777	CbGeAlD
Amiodarone—Phlebitis—Etoposide—brain cancer	0.000355	0.00214	CcSEcCtD
Amiodarone—ADRB1—head—brain cancer	0.000351	0.00767	CbGeAlD
Amiodarone—KCNH2—pituitary gland—brain cancer	0.000351	0.00766	CbGeAlD
Amiodarone—Muscular weakness—Carmustine—brain cancer	0.000349	0.0021	CcSEcCtD
Amiodarone—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.000344	0.00208	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.000344	0.00208	CcSEcCtD
Amiodarone—KCNH2—medulla oblongata—brain cancer	0.000338	0.00739	CbGeAlD
Amiodarone—Cardiac failure congestive—Etoposide—brain cancer	0.000337	0.00203	CcSEcCtD
Amiodarone—Alanine aminotransferase increased—Temozolomide—brain cancer	0.000337	0.00203	CcSEcCtD
Amiodarone—Muscular weakness—Temozolomide—brain cancer	0.000337	0.00203	CcSEcCtD
Amiodarone—Hallucination—Hydroxyurea—brain cancer	0.000336	0.00203	CcSEcCtD
Amiodarone—Cough—Procarbazine—brain cancer	0.000332	0.002	CcSEcCtD
Amiodarone—Pancytopenia—Carmustine—brain cancer	0.000324	0.00196	CcSEcCtD
Amiodarone—Anxiety—Procarbazine—brain cancer	0.000323	0.00195	CcSEcCtD
Amiodarone—CYP2C8—pituitary gland—brain cancer	0.000321	0.00701	CbGeAlD
Amiodarone—ADRB1—central nervous system—brain cancer	0.000321	0.007	CbGeAlD
Amiodarone—Neutropenia—Carmustine—brain cancer	0.000319	0.00193	CcSEcCtD
Amiodarone—CYP2A6—brain—brain cancer	0.000317	0.00692	CbGeAlD
Amiodarone—Dry mouth—Procarbazine—brain cancer	0.000317	0.00191	CcSEcCtD
Amiodarone—Anaphylactoid reaction—Etoposide—brain cancer	0.000316	0.00191	CcSEcCtD
Amiodarone—Pancytopenia—Temozolomide—brain cancer	0.000313	0.00189	CcSEcCtD
Amiodarone—Cardiac failure—Etoposide—brain cancer	0.000313	0.00189	CcSEcCtD
Amiodarone—Confusional state—Procarbazine—brain cancer	0.000313	0.00189	CcSEcCtD
Amiodarone—Vomiting—Lomustine—brain cancer	0.000311	0.00188	CcSEcCtD
Amiodarone—Oedema—Procarbazine—brain cancer	0.00031	0.00187	CcSEcCtD
Amiodarone—KCNH2—midbrain—brain cancer	0.000309	0.00675	CbGeAlD
Amiodarone—Neutropenia—Temozolomide—brain cancer	0.000309	0.00186	CcSEcCtD
Amiodarone—Infection—Procarbazine—brain cancer	0.000308	0.00186	CcSEcCtD
Amiodarone—Pneumonia—Carmustine—brain cancer	0.000306	0.00185	CcSEcCtD
Amiodarone—Shock—Procarbazine—brain cancer	0.000305	0.00184	CcSEcCtD
Amiodarone—Erectile dysfunction—Temozolomide—brain cancer	0.000304	0.00184	CcSEcCtD
Amiodarone—Thrombocytopenia—Procarbazine—brain cancer	0.000304	0.00184	CcSEcCtD
Amiodarone—Tachycardia—Procarbazine—brain cancer	0.000303	0.00183	CcSEcCtD
Amiodarone—KCNH2—spinal cord—brain cancer	0.000302	0.00659	CbGeAlD
Amiodarone—Photosensitivity reaction—Temozolomide—brain cancer	0.000301	0.00182	CcSEcCtD
Amiodarone—SIGMAR1—cerebellum—brain cancer	0.000301	0.00656	CbGeAlD
Amiodarone—Weight increased—Temozolomide—brain cancer	0.0003	0.00181	CcSEcCtD
Amiodarone—Hyperhidrosis—Procarbazine—brain cancer	0.0003	0.00181	CcSEcCtD
Amiodarone—Renal failure—Carmustine—brain cancer	0.000299	0.00181	CcSEcCtD
Amiodarone—Alopecia—Hydroxyurea—brain cancer	0.000299	0.0018	CcSEcCtD
Amiodarone—Weight decreased—Temozolomide—brain cancer	0.000299	0.0018	CcSEcCtD
Amiodarone—Neuropathy peripheral—Carmustine—brain cancer	0.000299	0.0018	CcSEcCtD
Amiodarone—Pneumonia—Temozolomide—brain cancer	0.000296	0.00179	CcSEcCtD
Amiodarone—CYP2D6—brainstem—brain cancer	0.000296	0.00646	CbGeAlD
Amiodarone—Anorexia—Procarbazine—brain cancer	0.000296	0.00179	CcSEcCtD
Amiodarone—Erythema—Hydroxyurea—brain cancer	0.000294	0.00178	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000292	0.00176	CcSEcCtD
Amiodarone—Cardiac arrest—Etoposide—brain cancer	0.000291	0.00175	CcSEcCtD
Amiodarone—Nausea—Lomustine—brain cancer	0.00029	0.00175	CcSEcCtD
Amiodarone—Hypotension—Procarbazine—brain cancer	0.00029	0.00175	CcSEcCtD
Amiodarone—Neuropathy peripheral—Temozolomide—brain cancer	0.000288	0.00174	CcSEcCtD
Amiodarone—CYP2C19—endocrine gland—brain cancer	0.000285	0.00622	CbGeAlD
Amiodarone—Insomnia—Procarbazine—brain cancer	0.000281	0.0017	CcSEcCtD
Amiodarone—Paraesthesia—Procarbazine—brain cancer	0.000279	0.00168	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000275	0.00166	CcSEcCtD
Amiodarone—Ill-defined disorder—Hydroxyurea—brain cancer	0.000273	0.00165	CcSEcCtD
Amiodarone—Hallucination—Carmustine—brain cancer	0.000272	0.00164	CcSEcCtD
Amiodarone—KCNH2—endocrine gland—brain cancer	0.000272	0.00593	CbGeAlD
Amiodarone—Decreased appetite—Procarbazine—brain cancer	0.00027	0.00163	CcSEcCtD
Amiodarone—Alanine aminotransferase increased—Etoposide—brain cancer	0.00027	0.00163	CcSEcCtD
Amiodarone—KCNH2—head—brain cancer	0.000268	0.00586	CbGeAlD
Amiodarone—Fatigue—Procarbazine—brain cancer	0.000268	0.00162	CcSEcCtD
Amiodarone—Malaise—Hydroxyurea—brain cancer	0.000265	0.0016	CcSEcCtD
Amiodarone—Pain—Procarbazine—brain cancer	0.000265	0.0016	CcSEcCtD
Amiodarone—Constipation—Procarbazine—brain cancer	0.000265	0.0016	CcSEcCtD
Amiodarone—Hepatitis—Temozolomide—brain cancer	0.000264	0.00159	CcSEcCtD
Amiodarone—Visual impairment—Carmustine—brain cancer	0.000263	0.00159	CcSEcCtD
Amiodarone—Hallucination—Temozolomide—brain cancer	0.000263	0.00159	CcSEcCtD
Amiodarone—CYP2D6—telencephalon—brain cancer	0.000263	0.00574	CbGeAlD
Amiodarone—Bronchospasm—Etoposide—brain cancer	0.00026	0.00157	CcSEcCtD
Amiodarone—Feeling abnormal—Procarbazine—brain cancer	0.000256	0.00154	CcSEcCtD
Amiodarone—Visual impairment—Temozolomide—brain cancer	0.000255	0.00154	CcSEcCtD
Amiodarone—ADRB1—brain—brain cancer	0.000255	0.00556	CbGeAlD
Amiodarone—Gastrointestinal pain—Procarbazine—brain cancer	0.000254	0.00153	CcSEcCtD
Amiodarone—Flushing—Carmustine—brain cancer	0.000254	0.00153	CcSEcCtD
Amiodarone—Pancytopenia—Etoposide—brain cancer	0.000251	0.00151	CcSEcCtD
Amiodarone—Erythema multiforme—Temozolomide—brain cancer	0.00025	0.00151	CcSEcCtD
Amiodarone—CYP2C8—endocrine gland—brain cancer	0.000249	0.00543	CbGeAlD
Amiodarone—Discomfort—Hydroxyurea—brain cancer	0.000248	0.00149	CcSEcCtD
Amiodarone—Neutropenia—Etoposide—brain cancer	0.000247	0.00149	CcSEcCtD
Amiodarone—Urticaria—Procarbazine—brain cancer	0.000247	0.00149	CcSEcCtD
Amiodarone—Tinnitus—Temozolomide—brain cancer	0.000246	0.00149	CcSEcCtD
Amiodarone—Abdominal pain—Procarbazine—brain cancer	0.000245	0.00148	CcSEcCtD
Amiodarone—Body temperature increased—Procarbazine—brain cancer	0.000245	0.00148	CcSEcCtD
Amiodarone—Flushing—Temozolomide—brain cancer	0.000245	0.00148	CcSEcCtD
Amiodarone—KCNH2—central nervous system—brain cancer	0.000245	0.00535	CbGeAlD
Amiodarone—Arrhythmia—Carmustine—brain cancer	0.000244	0.00147	CcSEcCtD
Amiodarone—SIGMAR1—brain—brain cancer	0.000244	0.00533	CbGeAlD
Amiodarone—Alopecia—Carmustine—brain cancer	0.000242	0.00146	CcSEcCtD
Amiodarone—Oedema—Hydroxyurea—brain cancer	0.00024	0.00145	CcSEcCtD
Amiodarone—KCNH2—cerebellum—brain cancer	0.000239	0.00522	CbGeAlD
Amiodarone—Infection—Hydroxyurea—brain cancer	0.000239	0.00144	CcSEcCtD
Amiodarone—Erythema—Carmustine—brain cancer	0.000238	0.00144	CcSEcCtD
Amiodarone—Pneumonia—Etoposide—brain cancer	0.000237	0.00143	CcSEcCtD
Amiodarone—Thrombocytopenia—Hydroxyurea—brain cancer	0.000235	0.00142	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000233	0.00141	CcSEcCtD
Amiodarone—Alopecia—Temozolomide—brain cancer	0.000233	0.00141	CcSEcCtD
Amiodarone—Skin disorder—Hydroxyurea—brain cancer	0.000233	0.00141	CcSEcCtD
Amiodarone—CYP1A2—endocrine gland—brain cancer	0.000233	0.00508	CbGeAlD
Amiodarone—Renal failure—Etoposide—brain cancer	0.000231	0.0014	CcSEcCtD
Amiodarone—Neuropathy peripheral—Etoposide—brain cancer	0.000231	0.00139	CcSEcCtD
Amiodarone—Back pain—Carmustine—brain cancer	0.00023	0.00139	CcSEcCtD
Amiodarone—Erythema—Temozolomide—brain cancer	0.00023	0.00139	CcSEcCtD
Amiodarone—Jaundice—Etoposide—brain cancer	0.00023	0.00139	CcSEcCtD
Amiodarone—CYP1A1—endocrine gland—brain cancer	0.000229	0.00501	CbGeAlD
Amiodarone—Anorexia—Hydroxyurea—brain cancer	0.000229	0.00138	CcSEcCtD
Amiodarone—Hypersensitivity—Procarbazine—brain cancer	0.000229	0.00138	CcSEcCtD
Amiodarone—CYP1A1—head—brain cancer	0.000227	0.00495	CbGeAlD
Amiodarone—Dysgeusia—Temozolomide—brain cancer	0.000225	0.00136	CcSEcCtD
Amiodarone—CYP3A5—endocrine gland—brain cancer	0.000224	0.0049	CbGeAlD
Amiodarone—Vision blurred—Carmustine—brain cancer	0.000224	0.00135	CcSEcCtD
Amiodarone—Tremor—Carmustine—brain cancer	0.000223	0.00135	CcSEcCtD
Amiodarone—Asthenia—Procarbazine—brain cancer	0.000223	0.00134	CcSEcCtD
Amiodarone—Back pain—Temozolomide—brain cancer	0.000222	0.00134	CcSEcCtD
Amiodarone—CYP2C9—endocrine gland—brain cancer	0.000221	0.00482	CbGeAlD
Amiodarone—Agranulocytosis—Etoposide—brain cancer	0.00022	0.00133	CcSEcCtD
Amiodarone—Pruritus—Procarbazine—brain cancer	0.00022	0.00133	CcSEcCtD
Amiodarone—Agitation—Carmustine—brain cancer	0.000219	0.00132	CcSEcCtD
Amiodarone—Vision blurred—Temozolomide—brain cancer	0.000217	0.00131	CcSEcCtD
Amiodarone—Tremor—Temozolomide—brain cancer	0.000215	0.0013	CcSEcCtD
Amiodarone—Dyspnoea—Hydroxyurea—brain cancer	0.000214	0.00129	CcSEcCtD
Amiodarone—Ill-defined disorder—Temozolomide—brain cancer	0.000213	0.00129	CcSEcCtD
Amiodarone—Diarrhoea—Procarbazine—brain cancer	0.000212	0.00128	CcSEcCtD
Amiodarone—Dyspepsia—Hydroxyurea—brain cancer	0.000211	0.00128	CcSEcCtD
Amiodarone—Agitation—Temozolomide—brain cancer	0.000211	0.00128	CcSEcCtD
Amiodarone—Angioedema—Temozolomide—brain cancer	0.00021	0.00127	CcSEcCtD
Amiodarone—Decreased appetite—Hydroxyurea—brain cancer	0.000209	0.00126	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000207	0.00125	CcSEcCtD
Amiodarone—Malaise—Temozolomide—brain cancer	0.000207	0.00125	CcSEcCtD
Amiodarone—Fatigue—Hydroxyurea—brain cancer	0.000207	0.00125	CcSEcCtD
Amiodarone—CYP1A1—central nervous system—brain cancer	0.000207	0.00451	CbGeAlD
Amiodarone—Vertigo—Temozolomide—brain cancer	0.000207	0.00125	CcSEcCtD
Amiodarone—Pain—Hydroxyurea—brain cancer	0.000205	0.00124	CcSEcCtD
Amiodarone—Constipation—Hydroxyurea—brain cancer	0.000205	0.00124	CcSEcCtD
Amiodarone—Dizziness—Procarbazine—brain cancer	0.000205	0.00124	CcSEcCtD
Amiodarone—EBP—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000203	0.00355	CbGpPWpGaD
Amiodarone—Anxiety—Carmustine—brain cancer	0.000202	0.00122	CcSEcCtD
Amiodarone—Cough—Temozolomide—brain cancer	0.000201	0.00121	CcSEcCtD
Amiodarone—Erythema multiforme—Etoposide—brain cancer	0.0002	0.00121	CcSEcCtD
Amiodarone—Feeling abnormal—Hydroxyurea—brain cancer	0.000198	0.0012	CcSEcCtD
Amiodarone—Vomiting—Procarbazine—brain cancer	0.000197	0.00119	CcSEcCtD
Amiodarone—Flushing—Etoposide—brain cancer	0.000196	0.00118	CcSEcCtD
Amiodarone—Confusional state—Carmustine—brain cancer	0.000196	0.00118	CcSEcCtD
Amiodarone—Rash—Procarbazine—brain cancer	0.000196	0.00118	CcSEcCtD
Amiodarone—Dermatitis—Procarbazine—brain cancer	0.000196	0.00118	CcSEcCtD
Amiodarone—Anxiety—Temozolomide—brain cancer	0.000195	0.00118	CcSEcCtD
Amiodarone—Headache—Procarbazine—brain cancer	0.000194	0.00117	CcSEcCtD
Amiodarone—KCNH2—brain—brain cancer	0.000194	0.00424	CbGeAlD
Amiodarone—Oedema—Carmustine—brain cancer	0.000194	0.00117	CcSEcCtD
Amiodarone—Discomfort—Temozolomide—brain cancer	0.000193	0.00117	CcSEcCtD
Amiodarone—Infection—Carmustine—brain cancer	0.000193	0.00116	CcSEcCtD
Amiodarone—Dry mouth—Temozolomide—brain cancer	0.000191	0.00116	CcSEcCtD
Amiodarone—Thrombocytopenia—Carmustine—brain cancer	0.00019	0.00115	CcSEcCtD
Amiodarone—Body temperature increased—Hydroxyurea—brain cancer	0.00019	0.00115	CcSEcCtD
Amiodarone—Tachycardia—Carmustine—brain cancer	0.00019	0.00114	CcSEcCtD
Amiodarone—Confusional state—Temozolomide—brain cancer	0.000189	0.00114	CcSEcCtD
Amiodarone—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000189	0.00331	CbGpPWpGaD
Amiodarone—ABCB1—telencephalon—brain cancer	0.000189	0.00413	CbGeAlD
Amiodarone—Oedema—Temozolomide—brain cancer	0.000188	0.00113	CcSEcCtD
Amiodarone—Anaphylactic shock—Temozolomide—brain cancer	0.000188	0.00113	CcSEcCtD
Amiodarone—Alopecia—Etoposide—brain cancer	0.000187	0.00113	CcSEcCtD
Amiodarone—Infection—Temozolomide—brain cancer	0.000186	0.00113	CcSEcCtD
Amiodarone—Anorexia—Carmustine—brain cancer	0.000185	0.00112	CcSEcCtD
Amiodarone—Nausea—Procarbazine—brain cancer	0.000184	0.00111	CcSEcCtD
Amiodarone—Thrombocytopenia—Temozolomide—brain cancer	0.000184	0.00111	CcSEcCtD
Amiodarone—Skin disorder—Temozolomide—brain cancer	0.000182	0.0011	CcSEcCtD
Amiodarone—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—brain cancer	0.000182	0.00319	CbGpPWpGaD
Amiodarone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000182	0.00319	CbGpPWpGaD
Amiodarone—Hypotension—Carmustine—brain cancer	0.000181	0.0011	CcSEcCtD
Amiodarone—Hyperhidrosis—Temozolomide—brain cancer	0.000181	0.0011	CcSEcCtD
Amiodarone—Dysgeusia—Etoposide—brain cancer	0.00018	0.00109	CcSEcCtD
Amiodarone—CYP3A7—Biological oxidations—CYP2C9—brain cancer	0.00018	0.00315	CbGpPWpGaD
Amiodarone—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000179	0.00314	CbGpPWpGaD
Amiodarone—Anorexia—Temozolomide—brain cancer	0.000179	0.00108	CcSEcCtD
Amiodarone—Back pain—Etoposide—brain cancer	0.000178	0.00107	CcSEcCtD
Amiodarone—CYP1A1—Oxidative Stress—SOD2—brain cancer	0.000178	0.00312	CbGpPWpGaD
Amiodarone—CYP2C8—brain—brain cancer	0.000178	0.00388	CbGeAlD
Amiodarone—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	0.000177	0.00311	CbGpPWpGaD
Amiodarone—Hypersensitivity—Hydroxyurea—brain cancer	0.000177	0.00107	CcSEcCtD
Amiodarone—Insomnia—Carmustine—brain cancer	0.000176	0.00106	CcSEcCtD
Amiodarone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000175	0.00306	CbGpPWpGaD
Amiodarone—Paraesthesia—Carmustine—brain cancer	0.000174	0.00105	CcSEcCtD
Amiodarone—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000174	0.00305	CbGpPWpGaD
Amiodarone—Dyspnoea—Carmustine—brain cancer	0.000173	0.00105	CcSEcCtD
Amiodarone—Asthenia—Hydroxyurea—brain cancer	0.000172	0.00104	CcSEcCtD
Amiodarone—Ill-defined disorder—Etoposide—brain cancer	0.000171	0.00103	CcSEcCtD
Amiodarone—Insomnia—Temozolomide—brain cancer	0.00017	0.00102	CcSEcCtD
Amiodarone—Decreased appetite—Carmustine—brain cancer	0.000169	0.00102	CcSEcCtD
Amiodarone—Paraesthesia—Temozolomide—brain cancer	0.000169	0.00102	CcSEcCtD
Amiodarone—CYP3A4—endocrine gland—brain cancer	0.000168	0.00368	CbGeAlD
Amiodarone—Gastrointestinal disorder—Carmustine—brain cancer	0.000168	0.00101	CcSEcCtD
Amiodarone—Dyspnoea—Temozolomide—brain cancer	0.000167	0.00101	CcSEcCtD
Amiodarone—Pain—Carmustine—brain cancer	0.000166	0.001	CcSEcCtD
Amiodarone—Constipation—Carmustine—brain cancer	0.000166	0.001	CcSEcCtD
Amiodarone—Malaise—Etoposide—brain cancer	0.000166	0.001	CcSEcCtD
Amiodarone—CACNA1H—Corticotropin-releasing hormone—RELA—brain cancer	0.000166	0.0029	CbGpPWpGaD
Amiodarone—CYP2D6—endocrine gland—brain cancer	0.000166	0.00362	CbGeAlD
Amiodarone—Vertigo—Etoposide—brain cancer	0.000165	0.000998	CcSEcCtD
Amiodarone—Dyspepsia—Temozolomide—brain cancer	0.000165	0.000997	CcSEcCtD
Amiodarone—CYP2A6—Biological oxidations—CYP2C9—brain cancer	0.000165	0.00289	CbGpPWpGaD
Amiodarone—Diarrhoea—Hydroxyurea—brain cancer	0.000164	0.000992	CcSEcCtD
Amiodarone—CYP1A1—brain—brain cancer	0.000164	0.00358	CbGeAlD
Amiodarone—CYP2D6—head—brain cancer	0.000164	0.00357	CbGeAlD
Amiodarone—Decreased appetite—Temozolomide—brain cancer	0.000163	0.000985	CcSEcCtD
Amiodarone—CACNA1H—Axon guidance—TRPC6—brain cancer	0.000163	0.00285	CbGpPWpGaD
Amiodarone—Gastrointestinal disorder—Temozolomide—brain cancer	0.000162	0.000978	CcSEcCtD
Amiodarone—Fatigue—Temozolomide—brain cancer	0.000162	0.000977	CcSEcCtD
Amiodarone—Cough—Etoposide—brain cancer	0.000161	0.000969	CcSEcCtD
Amiodarone—Pain—Temozolomide—brain cancer	0.000161	0.000969	CcSEcCtD
Amiodarone—Constipation—Temozolomide—brain cancer	0.000161	0.000969	CcSEcCtD
Amiodarone—Feeling abnormal—Carmustine—brain cancer	0.00016	0.000966	CcSEcCtD
Amiodarone—Dizziness—Hydroxyurea—brain cancer	0.000159	0.000959	CcSEcCtD
Amiodarone—Gastrointestinal pain—Carmustine—brain cancer	0.000159	0.000959	CcSEcCtD
Amiodarone—ABCB1—gonad—brain cancer	0.000158	0.00344	CbGeAlD
Amiodarone—Discomfort—Etoposide—brain cancer	0.000155	0.000935	CcSEcCtD
Amiodarone—Feeling abnormal—Temozolomide—brain cancer	0.000155	0.000934	CcSEcCtD
Amiodarone—ABCB1—pituitary gland—brain cancer	0.000154	0.00336	CbGeAlD
Amiodarone—Abdominal pain—Carmustine—brain cancer	0.000154	0.000927	CcSEcCtD
Amiodarone—Body temperature increased—Carmustine—brain cancer	0.000154	0.000927	CcSEcCtD
Amiodarone—Gastrointestinal pain—Temozolomide—brain cancer	0.000153	0.000927	CcSEcCtD
Amiodarone—Vomiting—Hydroxyurea—brain cancer	0.000153	0.000922	CcSEcCtD
Amiodarone—CYP1A1—Estrogen Receptor Pathway—STAT3—brain cancer	0.000152	0.00267	CbGpPWpGaD
Amiodarone—CYP3A4—central nervous system—brain cancer	0.000152	0.00331	CbGeAlD
Amiodarone—Rash—Hydroxyurea—brain cancer	0.000151	0.000915	CcSEcCtD
Amiodarone—Confusional state—Etoposide—brain cancer	0.000151	0.000914	CcSEcCtD
Amiodarone—Dermatitis—Hydroxyurea—brain cancer	0.000151	0.000914	CcSEcCtD
Amiodarone—Headache—Hydroxyurea—brain cancer	0.000151	0.000909	CcSEcCtD
Amiodarone—Anaphylactic shock—Etoposide—brain cancer	0.00015	0.000907	CcSEcCtD
Amiodarone—CYP2D6—central nervous system—brain cancer	0.000149	0.00326	CbGeAlD
Amiodarone—CACNA1H—Corticotropin-releasing hormone—IL2—brain cancer	0.000149	0.00262	CbGpPWpGaD
Amiodarone—Infection—Etoposide—brain cancer	0.000149	0.000901	CcSEcCtD
Amiodarone—Urticaria—Temozolomide—brain cancer	0.000149	0.0009	CcSEcCtD
Amiodarone—ABCB1—medulla oblongata—brain cancer	0.000148	0.00324	CbGeAlD
Amiodarone—Body temperature increased—Temozolomide—brain cancer	0.000148	0.000896	CcSEcCtD
Amiodarone—Abdominal pain—Temozolomide—brain cancer	0.000148	0.000896	CcSEcCtD
Amiodarone—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000147	0.00258	CbGpPWpGaD
Amiodarone—Thrombocytopenia—Etoposide—brain cancer	0.000147	0.000888	CcSEcCtD
Amiodarone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000147	0.00257	CbGpPWpGaD
Amiodarone—Tachycardia—Etoposide—brain cancer	0.000147	0.000885	CcSEcCtD
Amiodarone—CYP2D6—cerebellum—brain cancer	0.000146	0.00319	CbGeAlD
Amiodarone—Skin disorder—Etoposide—brain cancer	0.000146	0.000881	CcSEcCtD
Amiodarone—Hyperhidrosis—Etoposide—brain cancer	0.000145	0.000877	CcSEcCtD
Amiodarone—CACNA1H—Corticotropin-releasing hormone—CTNNB1—brain cancer	0.000144	0.00253	CbGpPWpGaD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000144	0.00252	CbGpPWpGaD
Amiodarone—Anorexia—Etoposide—brain cancer	0.000143	0.000864	CcSEcCtD
Amiodarone—Hypersensitivity—Carmustine—brain cancer	0.000143	0.000864	CcSEcCtD
Amiodarone—Nausea—Hydroxyurea—brain cancer	0.000143	0.000862	CcSEcCtD
Amiodarone—Hypotension—Etoposide—brain cancer	0.00014	0.000847	CcSEcCtD
Amiodarone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00014	0.00246	CbGpPWpGaD
Amiodarone—THRA—Generic Transcription Pathway—ESR2—brain cancer	0.00014	0.00245	CbGpPWpGaD
Amiodarone—THRB—Generic Transcription Pathway—ESR2—brain cancer	0.00014	0.00245	CbGpPWpGaD
Amiodarone—Asthenia—Carmustine—brain cancer	0.000139	0.000841	CcSEcCtD
Amiodarone—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000138	0.00243	CbGpPWpGaD
Amiodarone—Hypersensitivity—Temozolomide—brain cancer	0.000138	0.000835	CcSEcCtD
Amiodarone—ABCB1—midbrain—brain cancer	0.000136	0.00296	CbGeAlD
Amiodarone—Paraesthesia—Etoposide—brain cancer	0.000135	0.000814	CcSEcCtD
Amiodarone—Asthenia—Temozolomide—brain cancer	0.000135	0.000813	CcSEcCtD
Amiodarone—Dyspnoea—Etoposide—brain cancer	0.000134	0.000808	CcSEcCtD
Amiodarone—Diarrhoea—Carmustine—brain cancer	0.000133	0.000802	CcSEcCtD
Amiodarone—Pruritus—Temozolomide—brain cancer	0.000133	0.000802	CcSEcCtD
Amiodarone—ABCB1—spinal cord—brain cancer	0.000132	0.00289	CbGeAlD
Amiodarone—THRA—Generic Transcription Pathway—NOTCH2—brain cancer	0.000132	0.00232	CbGpPWpGaD
Amiodarone—THRB—Generic Transcription Pathway—NOTCH2—brain cancer	0.000132	0.00232	CbGpPWpGaD
Amiodarone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000131	0.00229	CbGpPWpGaD
Amiodarone—Decreased appetite—Etoposide—brain cancer	0.000131	0.000788	CcSEcCtD
Amiodarone—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.00013	0.00228	CbGpPWpGaD
Amiodarone—Gastrointestinal disorder—Etoposide—brain cancer	0.00013	0.000783	CcSEcCtD
Amiodarone—Fatigue—Etoposide—brain cancer	0.000129	0.000782	CcSEcCtD
Amiodarone—THRB—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000129	0.00226	CbGpPWpGaD
Amiodarone—Dizziness—Carmustine—brain cancer	0.000128	0.000775	CcSEcCtD
Amiodarone—Constipation—Etoposide—brain cancer	0.000128	0.000775	CcSEcCtD
Amiodarone—Pain—Etoposide—brain cancer	0.000128	0.000775	CcSEcCtD
Amiodarone—Diarrhoea—Temozolomide—brain cancer	0.000128	0.000775	CcSEcCtD
Amiodarone—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000128	0.00225	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000127	0.00222	CbGpPWpGaD
Amiodarone—Dizziness—Temozolomide—brain cancer	0.000124	0.000749	CcSEcCtD
Amiodarone—Feeling abnormal—Etoposide—brain cancer	0.000124	0.000747	CcSEcCtD
Amiodarone—EBP—Metabolism—CYP2C9—brain cancer	0.000124	0.00217	CbGpPWpGaD
Amiodarone—Vomiting—Carmustine—brain cancer	0.000123	0.000746	CcSEcCtD
Amiodarone—Gastrointestinal pain—Etoposide—brain cancer	0.000123	0.000741	CcSEcCtD
Amiodarone—CYP1A1—Biological oxidations—CYP2C9—brain cancer	0.000123	0.00215	CbGpPWpGaD
Amiodarone—Rash—Carmustine—brain cancer	0.000122	0.000739	CcSEcCtD
Amiodarone—Dermatitis—Carmustine—brain cancer	0.000122	0.000739	CcSEcCtD
Amiodarone—Headache—Carmustine—brain cancer	0.000122	0.000735	CcSEcCtD
Amiodarone—CYP1A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000121	0.00212	CbGpPWpGaD
Amiodarone—Vomiting—Temozolomide—brain cancer	0.000119	0.00072	CcSEcCtD
Amiodarone—Urticaria—Etoposide—brain cancer	0.000119	0.00072	CcSEcCtD
Amiodarone—ABCB1—endocrine gland—brain cancer	0.000119	0.0026	CbGeAlD
Amiodarone—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000119	0.00209	CbGpPWpGaD
Amiodarone—Abdominal pain—Etoposide—brain cancer	0.000119	0.000717	CcSEcCtD
Amiodarone—Body temperature increased—Etoposide—brain cancer	0.000119	0.000717	CcSEcCtD
Amiodarone—CYP2D6—brain—brain cancer	0.000119	0.00259	CbGeAlD
Amiodarone—Rash—Temozolomide—brain cancer	0.000118	0.000714	CcSEcCtD
Amiodarone—Dermatitis—Temozolomide—brain cancer	0.000118	0.000714	CcSEcCtD
Amiodarone—ABCB1—head—brain cancer	0.000118	0.00257	CbGeAlD
Amiodarone—Headache—Temozolomide—brain cancer	0.000118	0.00071	CcSEcCtD
Amiodarone—CACNA1H—Developmental Biology—TRPC6—brain cancer	0.000116	0.00204	CbGpPWpGaD
Amiodarone—Nausea—Carmustine—brain cancer	0.000115	0.000696	CcSEcCtD
Amiodarone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000114	0.00199	CbGpPWpGaD
Amiodarone—THRB—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000113	0.00199	CbGpPWpGaD
Amiodarone—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000113	0.00197	CbGpPWpGaD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—HES1—brain cancer	0.000112	0.00196	CbGpPWpGaD
Amiodarone—Nausea—Temozolomide—brain cancer	0.000111	0.000673	CcSEcCtD
Amiodarone—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000111	0.00195	CbGpPWpGaD
Amiodarone—Hypersensitivity—Etoposide—brain cancer	0.000111	0.000668	CcSEcCtD
Amiodarone—Asthenia—Etoposide—brain cancer	0.000108	0.000651	CcSEcCtD
Amiodarone—ABCB1—central nervous system—brain cancer	0.000107	0.00235	CbGeAlD
Amiodarone—Pruritus—Etoposide—brain cancer	0.000106	0.000642	CcSEcCtD
Amiodarone—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000106	0.00185	CbGpPWpGaD
Amiodarone—EBP—Metabolism—BSG—brain cancer	0.000105	0.00184	CbGpPWpGaD
Amiodarone—ABCB1—cerebellum—brain cancer	0.000105	0.00229	CbGeAlD
Amiodarone—Diarrhoea—Etoposide—brain cancer	0.000103	0.00062	CcSEcCtD
Amiodarone—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.0001	0.00176	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—PTCH2—brain cancer	9.98e-05	0.00175	CbGpPWpGaD
Amiodarone—Dizziness—Etoposide—brain cancer	9.93e-05	0.0006	CcSEcCtD
Amiodarone—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	9.91e-05	0.00174	CbGpPWpGaD
Amiodarone—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	9.7e-05	0.0017	CbGpPWpGaD
Amiodarone—Vomiting—Etoposide—brain cancer	9.55e-05	0.000577	CcSEcCtD
Amiodarone—Rash—Etoposide—brain cancer	9.47e-05	0.000572	CcSEcCtD
Amiodarone—Dermatitis—Etoposide—brain cancer	9.46e-05	0.000571	CcSEcCtD
Amiodarone—Headache—Etoposide—brain cancer	9.41e-05	0.000568	CcSEcCtD
Amiodarone—CYP2D6—Biological oxidations—CYP2C9—brain cancer	9.24e-05	0.00162	CbGpPWpGaD
Amiodarone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	9.15e-05	0.0016	CbGpPWpGaD
Amiodarone—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	9.11e-05	0.0016	CbGpPWpGaD
Amiodarone—EBP—Metabolism—IDH1—brain cancer	9.03e-05	0.00158	CbGpPWpGaD
Amiodarone—Nausea—Etoposide—brain cancer	8.92e-05	0.000539	CcSEcCtD
Amiodarone—CACNA2D2—Metabolism—CYP2C9—brain cancer	8.8e-05	0.00154	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—OR14C36—brain cancer	8.75e-05	0.00153	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—OR4C12—brain cancer	8.75e-05	0.00153	CbGpPWpGaD
Amiodarone—ABCB1—brain—brain cancer	8.53e-05	0.00186	CbGeAlD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	8.07e-05	0.00141	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—OR14C36—brain cancer	7.95e-05	0.00139	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—OR4C12—brain cancer	7.95e-05	0.00139	CbGpPWpGaD
Amiodarone—CYP1A2—Biological oxidations—CYP2C9—brain cancer	7.83e-05	0.00137	CbGpPWpGaD
Amiodarone—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	7.72e-05	0.00135	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—HES1—brain cancer	7.49e-05	0.00131	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—DNMT1—brain cancer	7.48e-05	0.00131	CbGpPWpGaD
Amiodarone—THRA—Gene Expression—DNMT1—brain cancer	7.48e-05	0.00131	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—BSG—brain cancer	7.48e-05	0.00131	CbGpPWpGaD
Amiodarone—CYP2A6—Fluoropyrimidine Activity—TP53—brain cancer	7.39e-05	0.0013	CbGpPWpGaD
Amiodarone—EBP—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.35e-05	0.00129	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor—RELA—brain cancer	7.3e-05	0.00128	CbGpPWpGaD
Amiodarone—EBP—Metabolism—ENO2—brain cancer	7.14e-05	0.00125	CbGpPWpGaD
Amiodarone—THRA—Gene Expression—ESR2—brain cancer	6.72e-05	0.00118	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—ESR2—brain cancer	6.72e-05	0.00118	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	6.58e-05	0.00115	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—IDH1—brain cancer	6.43e-05	0.00113	CbGpPWpGaD
Amiodarone—THRA—Gene Expression—NOTCH2—brain cancer	6.36e-05	0.00112	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—NOTCH2—brain cancer	6.36e-05	0.00112	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—PDGFRA—brain cancer	6.25e-05	0.00109	CbGpPWpGaD
Amiodarone—CYP3A4—Biological oxidations—CYP2C9—brain cancer	6.04e-05	0.00106	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—ERBB2—brain cancer	6.01e-05	0.00105	CbGpPWpGaD
Amiodarone—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	5.96e-05	0.00104	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—CDK4—brain cancer	5.87e-05	0.00103	CbGpPWpGaD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—CTNNB1—brain cancer	5.6e-05	0.000982	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	5.59e-05	0.00098	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—SIRT1—brain cancer	5.41e-05	0.000948	CbGpPWpGaD
Amiodarone—THRA—Gene Expression—SIRT1—brain cancer	5.41e-05	0.000948	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	5.21e-05	0.000913	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor—MYC—brain cancer	5.14e-05	0.000902	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—SHH—brain cancer	5.14e-05	0.000901	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PTCH2—brain cancer	5.12e-05	0.000898	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—ENO2—brain cancer	5.09e-05	0.000892	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	5.03e-05	0.000882	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	5.03e-05	0.000882	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	4.94e-05	0.000866	CbGpPWpGaD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—VEGFA—brain cancer	4.93e-05	0.000864	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—PTCH1—brain cancer	4.87e-05	0.000854	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—SMO—brain cancer	4.87e-05	0.000854	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.71e-05	0.000826	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—OR4C12—brain cancer	4.69e-05	0.000823	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—OR14C36—brain cancer	4.69e-05	0.000823	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	4.66e-05	0.000816	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—VEGFA—brain cancer	4.63e-05	0.000812	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—ABR—brain cancer	4.43e-05	0.000776	CbGpPWpGaD
Amiodarone—THRA—Generic Transcription Pathway—MYC—brain cancer	4.4e-05	0.000772	CbGpPWpGaD
Amiodarone—THRB—Generic Transcription Pathway—MYC—brain cancer	4.4e-05	0.000772	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.32e-05	0.000757	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	4.32e-05	0.000757	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—RELA—brain cancer	4.32e-05	0.000757	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—ERBB2—brain cancer	4.29e-05	0.000752	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	4.19e-05	0.000735	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	4.17e-05	0.000731	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—EGFR—brain cancer	4.17e-05	0.000731	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—ABR—brain cancer	4.02e-05	0.000704	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—DTX2—brain cancer	3.99e-05	0.0007	CbGpPWpGaD
Amiodarone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	3.91e-05	0.000685	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.86e-05	0.000676	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—CTNNB1—brain cancer	3.75e-05	0.000658	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	3.56e-05	0.000625	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.45e-05	0.000604	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	3.42e-05	0.0006	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—IL2—brain cancer	3.41e-05	0.000597	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	3.36e-05	0.000589	CbGpPWpGaD
Amiodarone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	3.34e-05	0.000586	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	3.32e-05	0.000581	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—VEGFA—brain cancer	3.31e-05	0.000579	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	3.28e-05	0.000575	CbGpPWpGaD
Amiodarone—EBP—Metabolism—PIK3CG—brain cancer	3.27e-05	0.000574	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—STAT3—brain cancer	3.27e-05	0.000574	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	3.21e-05	0.000562	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.21e-05	0.000562	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.16e-05	0.000554	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	3.08e-05	0.00054	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—CYP2C9—brain cancer	3.07e-05	0.000539	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PTCH2—brain cancer	3.03e-05	0.00053	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.01e-05	0.000527	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—EGFR—brain cancer	2.97e-05	0.000521	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	2.94e-05	0.000515	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HES5—brain cancer	2.93e-05	0.000514	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—VEGFA—brain cancer	2.9e-05	0.000508	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—STRADA—brain cancer	2.84e-05	0.000499	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.82e-05	0.000494	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CYP2C9—brain cancer	2.82e-05	0.000494	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—TRPC6—brain cancer	2.8e-05	0.000491	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—SHH—brain cancer	2.64e-05	0.000462	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—BSG—brain cancer	2.61e-05	0.000458	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.57e-05	0.000451	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—TRPC6—brain cancer	2.54e-05	0.000446	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.54e-05	0.000445	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—SMO—brain cancer	2.5e-05	0.000438	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PTCH1—brain cancer	2.5e-05	0.000438	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—BSG—brain cancer	2.4e-05	0.00042	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.39e-05	0.000419	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—ABR—brain cancer	2.37e-05	0.000416	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—PIK3CG—brain cancer	2.33e-05	0.000409	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—GLI2—brain cancer	2.29e-05	0.000402	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—IDH1—brain cancer	2.25e-05	0.000394	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CYP2C9—brain cancer	2.22e-05	0.000389	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.2e-05	0.000385	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—GLI1—brain cancer	2.16e-05	0.000378	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—MYC—brain cancer	2.12e-05	0.000372	CbGpPWpGaD
Amiodarone—THRA—Gene Expression—MYC—brain cancer	2.12e-05	0.000372	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—VAV1—brain cancer	2.1e-05	0.000368	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CYP2C9—brain cancer	2.1e-05	0.000368	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—IDH1—brain cancer	2.06e-05	0.000361	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SUFU—brain cancer	2.04e-05	0.000358	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.99e-05	0.00035	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—GFAP—brain cancer	1.97e-05	0.000346	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CYP2C9—brain cancer	1.92e-05	0.000337	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—VAV1—brain cancer	1.91e-05	0.000334	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—BSG—brain cancer	1.89e-05	0.000331	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HEY1—brain cancer	1.87e-05	0.000328	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.86e-05	0.000325	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—DLL1—brain cancer	1.83e-05	0.000321	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—BSG—brain cancer	1.78e-05	0.000313	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—ENO2—brain cancer	1.78e-05	0.000311	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CYP2C9—brain cancer	1.72e-05	0.000301	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CYP2C9—brain cancer	1.68e-05	0.000294	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.64e-05	0.000287	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—BSG—brain cancer	1.64e-05	0.000287	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—ENO2—brain cancer	1.63e-05	0.000285	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—IDH1—brain cancer	1.62e-05	0.000285	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.62e-05	0.000285	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CYP2C9—brain cancer	1.58e-05	0.000277	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SHH—brain cancer	1.56e-05	0.000273	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—IDH1—brain cancer	1.53e-05	0.000269	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TRPC6—brain cancer	1.5e-05	0.000263	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PTCH1—brain cancer	1.48e-05	0.000259	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SMO—brain cancer	1.48e-05	0.000259	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—BSG—brain cancer	1.46e-05	0.000256	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.43e-05	0.000251	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—BSG—brain cancer	1.43e-05	0.00025	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—IDH1—brain cancer	1.41e-05	0.000247	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—BSG—brain cancer	1.34e-05	0.000235	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP2C9—brain cancer	1.34e-05	0.000235	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—PIK3CG—brain cancer	1.33e-05	0.000234	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—BSG—brain cancer	1.33e-05	0.000233	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.32e-05	0.000231	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.29e-05	0.000225	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ENO2—brain cancer	1.28e-05	0.000225	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—IDH1—brain cancer	1.26e-05	0.00022	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.25e-05	0.000219	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—IDH1—brain cancer	1.23e-05	0.000215	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ENO2—brain cancer	1.21e-05	0.000213	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PIK3CG—brain cancer	1.21e-05	0.000212	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NOTCH2—brain cancer	1.18e-05	0.000207	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—IDH1—brain cancer	1.16e-05	0.000202	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.15e-05	0.000201	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—IDH1—brain cancer	1.15e-05	0.000201	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—BSG—brain cancer	1.14e-05	0.000199	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—VAV1—brain cancer	1.13e-05	0.000197	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ENO2—brain cancer	1.11e-05	0.000195	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.08e-05	0.000189	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP2C9—brain cancer	1.03e-05	0.000181	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.02e-05	0.000179	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ENO2—brain cancer	9.93e-06	0.000174	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—IDH1—brain cancer	9.79e-06	0.000172	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ENO2—brain cancer	9.69e-06	0.00017	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HES1—brain cancer	9.68e-06	0.00017	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—IL2—brain cancer	9.38e-06	0.000164	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.32e-06	0.000163	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PDGFRA—brain cancer	9.22e-06	0.000162	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ENO2—brain cancer	9.13e-06	0.00016	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ENO2—brain cancer	9.05e-06	0.000159	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SPP1—brain cancer	8.95e-06	0.000157	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—BSG—brain cancer	8.78e-06	0.000154	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—IL2—brain cancer	8.52e-06	0.000149	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CG—brain cancer	8.15e-06	0.000143	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IRS2—brain cancer	8.1e-06	0.000142	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.97e-06	0.00014	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ENO2—brain cancer	7.74e-06	0.000136	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—IDH1—brain cancer	7.55e-06	0.000132	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CG—brain cancer	7.47e-06	0.000131	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CG—brain cancer	7.15e-06	0.000125	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—APC—brain cancer	7.15e-06	0.000125	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—EGFR—brain cancer	6.51e-06	0.000114	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ENO2—brain cancer	5.97e-06	0.000105	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CG—brain cancer	5.89e-06	0.000103	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—RELA—brain cancer	5.59e-06	9.79e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CG—brain cancer	5.57e-06	9.76e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—ERBB2—brain cancer	5.55e-06	9.73e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CG—brain cancer	5.1e-06	8.94e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL2—brain cancer	5.03e-06	8.82e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCND1—brain cancer	4.9e-06	8.6e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CTNNB1—brain cancer	4.86e-06	8.51e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CG—brain cancer	4.55e-06	7.98e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CG—brain cancer	4.44e-06	7.79e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—VEGFA—brain cancer	4.28e-06	7.49e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—STAT3—brain cancer	4.23e-06	7.42e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CG—brain cancer	4.19e-06	7.34e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CG—brain cancer	4.15e-06	7.28e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MYC—brain cancer	3.93e-06	6.9e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EGFR—brain cancer	3.85e-06	6.74e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CG—brain cancer	3.55e-06	6.22e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TP53—brain cancer	3.23e-06	5.66e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CG—brain cancer	2.74e-06	4.8e-05	CbGpPWpGaD
